In addition, with anti-PD-1/PD-L1 therapy, overall survival was higher in patients who did not receive conventional indications of antibiotics compared with that of tumor patients receiving antibiotics, suggesting that disruption of the gut microbiota after antibiotic administration affects the response to immune checkpoint blockade (79). The gene discussed is CD274; the disease is neoplasm.